small molecule

ACTONEL

RISEDRONATE SODIUM

Loss of exclusivityloss of exclusivity
CompanyALLERGAN PHARMACEUTICALS INTERNATIONAL LTD

Drug detail

Brand nameACTONEL
Active ingredientRISEDRONATE SODIUM
Strength30MG
Dosage formTABLET
RouteORAL
ModalitySmall molecule
FDA approvalMarch 1998
Marketing statusDISCN

Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the loss of exclusivity; estimates are projections, not legal advice.

ACTONEL patent cliff — loss of exclusivity — | CliffBio